In his first confirmation hearing, Robert F. Kennedy Jr. tried to distance himself from his past statements on abortion and ...

A Super Bowl ad for weight loss medications from telehealth company Hims & Hers is optimized to engage and infuriate ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Eli Lilly has announced plans to acquire Scorpion Therapeutics ... as per a consensus forecast by GlobalData, the parent company of Pharmaceutical Technology. PI3K inhibitors are directed toward the ...

The county recovered a $102 million settlement from opioid distributors and manufacturers through multi-district litigation ...

New Activin R-based medications can emerge as perfect solutions for balancing weight loss and muscle building, making a ...

California is not one of those states. Newsom in October rejected a $35 monthly insulin copay cap. In his veto message, he cited the state’s $100 million investment in insulin production as an example ...

After what some real estate experts are calling a capital crisis, momentum in Saskatchewan and Canada’s commercial real estate investment market is finally bouncing back. “Interest rates have ...

In conjunction with the 2025 J.P. Morgan Healthcare Conference, the analyst hosted an investor lunch with Ultragenyx Pharmaceutical ... On the commercial front, Ultragenyx plans to leverage ...

GlobalData is the parent company of Pharmaceutical Technology. Eli Lilly is focusing on expanding access to obesity treatments while leveraging new therapeutic indications and ensuring pricing ...